Urinary tract infections in the elderly: a review of disease characteristics and current treatment options

Rodriguez-Mañas L. Urinary tract infections in the elderly: a review of disease characteristics and current treatment options. Drugs in Context…

A new publication confirms the role of xyloglucan as a mucosa protector in the management of urinary tract infections

Esposito E et al. Effect of xyloglucan against Escherichia coli extraintestinal urinary tract infection: an in vivo study. Microb Physiol.…

We are proud to announce the publication of the clinical trial “Randomized, placebo-controlled trial of xyloglucan and gelose for the treatment of acute diarrhea in children"

Santos J. et al. Randomized, placebo-controlled trial of xyloglucan…

Utipro® Plus Webinar session

We are pleased to inform you about our first #webinar sessions❗ On October 30th we talked about #UTIPROPLUS and its use in uncomplicated #UTIs. 

Some KOLs presented their experiences…

UTIPRO® PLUS AF strengthens its presence in EUROPE

We are pleased to announce the launch of UTIPRO® PLUS AF in the Republic of Ireland.

UTIPRO® PLUS AF, in its composition free from ingredients of animal origin, has been recently launched…

Noventure is proud to announce the launch of XILAPLUS® in Estonia, Latvia and Lithuania by our partner company Miecys

Noventure is proud to announce the launch of XILAPLUS® in Estonia, Latvia and Lithuania by our partner company Miecys

XILAPLUS® is specifically formulated for the control and reduction of…